Article Correctness Is Author's Responsibility: Researchers Validate Link Between Genetic Variant and Poor Outcomes in Men with Advanced Prostate Cancer

In a new Cleveland Clinic-led study published in JAMA Oncology, researchers show that a testosterone-related genetic variant - HSD3B1(1245C) - is associated with more aggressive disease and shorter survival in men with metastatic prostate cancer.